Author:
Brown Todd T.,Cofrancesco Joseph
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Young J, Weber R, Rickenbach M, et al.: Lipid profiles for antiretroviral-naive patients starting PI-and NNRTI-based therapy in the Swiss HIV cohort study. Antivir Ther 2005, 10:585–591.
2. Cohen C, Nieto-Cisneros L, Zala C, et al.: Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial. Curr Med Res Opin 2005, 21:1683–1692.
3. Wood R, Phanuphak P, Cahn P, et al.: Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir. J Acquir Immune Defic Syndr 2004, 36:684–692.
4. Mobius U, Lubach-Ruitman M, Castro-Frenzel B, et al.:Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia. J Acquir Immune Defic Syndr 2005, 39:174–180.
5. Johnson M, Grinsztejn B, Rodriguez C, et al.: 96-week comparison of once-daily atazanavir/ritonavir and twicedaily lopinavir/ritonavir in patients with multiple virologic failures. AIDS 2006, 20:711–718.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献